Please login to the form below

Not currently logged in
Email:
Password:

bictegravir

This page shows the latest bictegravir news and features for those working in and with pharma, biotech and healthcare.

Gilead’s Biktarvy received EC approval for the treatment of HIV in paediatric populations

Gilead’s Biktarvy received EC approval for the treatment of HIV in paediatric populations

Gilead Sciences (Gilead) has announced that the European Commission (EC) has authorised a new low-dose tablet dosage form of Biktarvy (bictegravir/emtricitabine/tenofovir alafenamide) and an extension of its indication

Latest news

More from news
Approximately 2 fully matching, plus 22 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Medscape Medical Affairs

Medscape Medical Affairs enables all medical affairs professionals to take a more strategic leadership role, and maximize the impact of...

Latest intelligence

Tree
Pharma’s vital role in sustainability and corporate social responsibility
Pharma is in the spotlight as tough questions about sustainability commitments continue to arise...
Infographic: Therapy Watch Hyperlipidaemia
Our latest infographic offers an introduction to the real-world insights collected by our Hyperlipidaemia study....
Article: The rise of the healthcare influencer
In our latest article for Pharmaphorum Deep Dive, we explore the opportunities and benefits for healthcare companies in the online influencer space....